Newsroom

Luca Cicin-Sain
Interview
In the coronavirus pandemic, older people are particularly at risk from severe courses of COVID-19. However, other infectious diseases also affect them more than younger people. On the occasion of the International Day of Older Persons on 1 October, Prof Luka Cicin-Sain, Head of the Department "Viral Immunology", talks about the ageing of the immune system.
30.09.2021
Logos HZI und EMBL
News
EMBL and the six Helmholtz Centers of the Research Field Health (Helmholtz Health) are expanding their collaboration. The two research organisations are cooperating to expand the frontiers of health research and advance scientific progress for human health.
22.09.2021
Einladung
News
On 9 September 2021, the 13th TWINCORE Symposium took place. This year, too, the event was held online due to corona. Nevertheless, the webinar was a great success and attracted even more viewers than last year.
13.09.2021
Schaubild
News
New antibiotics are urgently needed in the fight against multi-resistant bacteria. The recently discovered darobactin is a potential candidate with resistance-breaking properties. This substance shows very good antimicrobial activity against some of the most problematic hospital germs. However, so far darobactin could only be produced in relatively small quantities, making detailed investigation and further development difficult. A team led by Dr Sebastian Groß from the Department of Microbial Natural Products at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) in Saarbrücken has now addressed this problem. The scientists published their results in the journal Chemical Science.
31.08.2021
Einladung
News
Data Scientists are in demand on the job market: all 18 Helmholtz Centers have already advertised several positions calling for skills in AI methods in 2021.
30.08.2021
Konzept für die nachhaltige Entdeckung und Entwicklung neuer Antibiotika
News
Increasingly insensitive to standard drugs: Multi-resistant pathogens are spreading worldwide and even in the near future could threaten the safe treatment of deadly infectious diseases. However, the urgent demand for new antimicrobial agents is offset by a glaring lack of investment into their research. In an article in Nature Reviews Chemistry, the international research alliance IRAADD, which is coordinated by HZI researcher and HIPS director Prof Rolf Müller, presents forward-looking strategies that could be used to solve the problem. Scientists at the German Center for Infection Research (DZIF) are playing a leading role.
20.08.2021

HZI in the media

... außerhalb des Magen-Darm-Traktes zu überleben. Das Helmholtz Zentrum für Infektionsforschung (HZI) bezeichnet die Clostridien als „ ...

12.05.2025
|
Frankfurter Rundschau online

Maximilians-Universität (JMU) Würzburg und des Würzburger Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) haben 2020 eine ...

11.05.2025
|
Medizin Aspekte

Im Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) in Saarbrücken wird Spitzenforschung betrieben. Jetzt bekommt ...

09.05.2025
|
Tagesschau

JMU) Würzburg, in cooperation with the Helmholtz Institute for RNA-based Infection Research (HIRI), have developed and refined a cutting-

08.05.2025
|
Bioengineer.org

In the “Microbelix” project from the Helmholtz Institute for Pharmaceutical Research in Saarland, citizens can send soil samples from

08.05.2025
|
techzle

triggers of future pandemics. A research team from the Helmholtz Center for Infection Research (HZI) and the Medical Center—University of

07.05.2025
|
Phys.org